Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Ossenkoppele

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
Cancer|October 1, 1987
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II non-Hodgkin's lymphoma of the upper digestive and respiratory tractG J Ossenkoppele, J J Mol, G B Snow, et al.
Leukemia|October 8, 2004
Gene expression profiling of minimal residual disease in acute myeloid leukaemia by novel multiplex-PCR-based methodC J Hess, F Denkers, G J Ossenkoppele, et al.
The Netherlands Journal of Medicine|May 22, 2014
Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologistsM W M van der Poel, W J Mulder, G J Ossenkoppele, et al.
Leukemia Research|March 1, 1995
Radiotoxicity of 67-gallium on myeloid leukemic blastsA R Jonkhoff, P C Huijgens, R T Versteegh, et al.
Leukemia|May 26, 2007
Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remissionA van Rhenen, B Moshaver, A Kelder, et al.
Journal of Clinical Pathology|July 27, 2000
ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before disseminationR L ten Berge, J J Oudejans, G J Ossenkoppele, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2003
[Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment ]M T Groot, G J Ossenkoppele, M H Kramer, et al.
Journal of Clinical Pathology|January 1, 1994
Relation of CD30 expression to survival and morphology in large cell B cell lymphomasL A Noorduyn, P C de Bruin, P van Heerde, et al.
Leukemia|November 21, 1998
Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cellsJ J Bijl, J W van Oostveen, J M Walboomers, et al.
Leukemia Research|March 1, 1993
Adhesive capacity of human long-term bone marrow cultures from normals and patients with acute myeloid leukaemia: the influence of adhesion moleculesI A Denkers, T J de Jong-de Boer, R H Beelen, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
Cancer|October 1, 1987
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II non-Hodgkin's lymphoma of the upper digestive and respiratory tractG J Ossenkoppele, J J Mol, G B Snow, et al.
Leukemia|October 8, 2004
Gene expression profiling of minimal residual disease in acute myeloid leukaemia by novel multiplex-PCR-based methodC J Hess, F Denkers, G J Ossenkoppele, et al.
The Netherlands Journal of Medicine|May 22, 2014
Comorbidity and treatment decision-making in elderly non-Hodgkin's lymphoma patients: a survey among haematologistsM W M van der Poel, W J Mulder, G J Ossenkoppele, et al.
Leukemia Research|March 1, 1995
Radiotoxicity of 67-gallium on myeloid leukemic blastsA R Jonkhoff, P C Huijgens, R T Versteegh, et al.
Leukemia|May 26, 2007
Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remissionA van Rhenen, B Moshaver, A Kelder, et al.
Journal of Clinical Pathology|July 27, 2000
ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before disseminationR L ten Berge, J J Oudejans, G J Ossenkoppele, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 12, 2003
[Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment ]M T Groot, G J Ossenkoppele, M H Kramer, et al.
Journal of Clinical Pathology|January 1, 1994
Relation of CD30 expression to survival and morphology in large cell B cell lymphomasL A Noorduyn, P C de Bruin, P van Heerde, et al.
Leukemia|November 21, 1998
Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cellsJ J Bijl, J W van Oostveen, J M Walboomers, et al.
Leukemia Research|March 1, 1993
Adhesive capacity of human long-term bone marrow cultures from normals and patients with acute myeloid leukaemia: the influence of adhesion moleculesI A Denkers, T J de Jong-de Boer, R H Beelen, et al.
Pageof 16